1. A randomized trial comparing 4.8 vs. 2.4 g/day of oral mesalazine for maintenance of remission in ulcerative colitis. Issue 11 (November 2015) Authors: Pica, Roberta; Cassieri, Claudio; Cocco, Andrea; Zippi, Maddalena; Marcheggiano, Adriana; De Nitto, Daniela; Avallone, Eleonora Veronica; Crispino, Pietro; Occhigrossi, Giuseppe; Paoluzi, Paolo Journal: Digestive and liver disease Issue: Volume 47:Issue 11(2015) Page Start: 933 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗